Complications associated with immunotherapy for brain metastases.
Sign Up to like & getrecommendations! Published in 2019 at "Current Opinion in Neurology"
DOI: 10.1097/wco.0000000000000756
Abstract: PURPOSE OF REVIEW Median survival after the diagnosis of brain metastases has historically been on the order of months. With the recent development of immune checkpoint inhibitors, intracranial activity and durable responses have been observed… read more here.
Keywords: complications associated; neurologic toxicities; immune therapy; associated immunotherapy ... See more keywords